Enhancing its peptide synthesis capabilities to meet increasing demand from its global partners for efficient and scalable ...

With over $410 million in financing; to advance portfolio of next-gen oral and injectable treatments with first- or ...

Excipient GMP certification validates the company's quality systems and process controls to support the cell and gene therapy ...